Login

Financial Snapshot

Revenue
TTM
$3.356M
Gross Margin
TTM
21.22%
Net Income
TTM
-$3.075M
Current Assets
2025 Q3
$26.04M
Current Liabilities
2025 Q3
$5.962M
Current Ratio
2025 Q3
436.84%
Total Assets
2025 Q3
$26.35M
Total Liabilities
2025 Q3
$6.120M
Book Value
2025 Q3
20.23M
Cash
2025 Q3
$21.17M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$2.346M

Stock Price

Loading...
Market Cap: $1.7054 Million

About China SXT Pharmaceuticals Inc

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.

Industry: Pharmaceutical Preparations Peers: China Pharma Holdings Inc SUNWIN STEVIA INTERNATIONAL, INC. BGM Group Ltd Universe Pharmaceuticals Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support